Daniel Recinella - Net Worth and Insider Trading

Daniel Recinella Net Worth

The estimated net worth of Daniel Recinella is at least $5,575 dollars as of 2024-04-20. Daniel Recinella is the VP - Product Development of AngioDynamics Inc and owns about 892 shares of AngioDynamics Inc (ANGO) stock worth over $5,575. Details can be seen in Daniel Recinella's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Daniel Recinella has not made any transactions after 2007-01-16 and currently still holds the listed stock(s).

Transaction Summary of Daniel Recinella

To

Daniel Recinella Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel Recinella owns 1 companies in total, including AngioDynamics Inc (ANGO) .

Click here to see the complete history of Daniel Recinella’s form 4 insider trades.

Insider Ownership Summary of Daniel Recinella

Ticker Comapny Transaction Date Type of Owner
ANGO AngioDynamics Inc 2007-01-16 VP - Product Development

Daniel Recinella Latest Holdings Summary

Daniel Recinella currently owns a total of 1 stock. Daniel Recinella owns 892 shares of AngioDynamics Inc (ANGO) as of January 16, 2007, with a value of $5,575.

Latest Holdings of Daniel Recinella

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
ANGO AngioDynamics Inc 2007-01-16 892 6.25 5,575

Holding Weightings of Daniel Recinella


Daniel Recinella Form 4 Trading Tracker

According to the SEC Form 4 filings, Daniel Recinella has made a total of 0 transactions in AngioDynamics Inc (ANGO) over the past 5 years. The most-recent trade in AngioDynamics Inc is the sale of 3,455 shares on January 16, 2007, which brought Daniel Recinella around $86,375.

Insider Trading History of Daniel Recinella

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Daniel Recinella Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel Recinella Ownership Network

Ownership Network List of Daniel Recinella

No Data

Ownership Network Relation of Daniel Recinella


Daniel Recinella Owned Company Details

What does AngioDynamics Inc do?

Who are the key executives at AngioDynamics Inc?

Daniel Recinella is the VP - Product Development of AngioDynamics Inc. Other key executives at AngioDynamics Inc include director & President and CEO James C Clemmer , SVP/GM & VIT Scott Centea , and SVP Global Operations and R&D Dave Helsel .

AngioDynamics Inc (ANGO) Insider Trades Summary

Over the past 18 months, Daniel Recinella made no insider transaction in AngioDynamics Inc (ANGO). Other recent insider transactions involving AngioDynamics Inc (ANGO) include a net purchase of 10,000 shares made by James C Clemmer , and a net sale of 4,633 shares made by Dave Helsel .

In summary, during the past 3 months, insiders sold 0 shares of AngioDynamics Inc (ANGO) in total and bought 10,000 shares, with a net purchase of 10,000 shares. During the past 18 months, 4,633 shares of AngioDynamics Inc (ANGO) were sold and 10,000 shares were bought by its insiders, resulting in a net purchase of 5,367 shares.

AngioDynamics Inc (ANGO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

AngioDynamics Inc Insider Transactions

No Available Data

Daniel Recinella Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel Recinella. Currently GuruFocus does not have mailing address information for Daniel Recinella.

Discussions on Daniel Recinella

No discussions yet.